Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Kidney Int ; 85(5): 1214-24, 2014 May.
Article in English | MEDLINE | ID: mdl-24429397

ABSTRACT

Here we studied plasma metabolomic profiles as determinants of progression to end-stage renal disease (ESRD) in patients with type 2 diabetes (T2D). This nested case-control study evaluated 40 cases who progressed to ESRD during 8-12 years of follow-up and 40 controls who remained alive without ESRD from the Joslin Kidney Study cohort. Controls were matched with cases for baseline clinical characteristics, although controls had slightly higher eGFR and lower levels of urinary albumin excretion than cases. Plasma metabolites at baseline were measured by mass spectrometry-based global metabolomic profiling. Of the named metabolites in the library, 262 were detected in at least 80% of the study patients. The metabolomic platform recognized 78 metabolites previously reported to be elevated in ESRD (uremic solutes). Sixteen were already elevated in the baseline plasma of our cases years before ESRD developed. Other uremic solutes were either not different or not commonly detectable. Essential amino acids and their derivatives were significantly depleted in the cases, whereas certain amino acid-derived acylcarnitines were increased. All findings remained statistically significant after adjustment for differences between study groups in albumin excretion rate, eGFR, or HbA1c. Uremic solute differences were confirmed by quantitative measurements. Thus, abnormal plasma concentrations of putative uremic solutes and essential amino acids either contribute to progression to ESRD or are a manifestation of an early stage(s) of the disease process that leads to ESRD in T2D.


Subject(s)
Amino Acids, Essential/blood , Diabetes Mellitus, Type 2/complications , Diabetic Nephropathies/etiology , Kidney Failure, Chronic/etiology , Metabolomics , Uremia/etiology , Aged , Biomarkers/blood , Boston , Case-Control Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/diagnosis , Diabetic Nephropathies/blood , Diabetic Nephropathies/diagnosis , Diabetic Nephropathies/physiopathology , Disease Progression , Female , Glomerular Filtration Rate , Glycated Hemoglobin/analysis , Humans , Kidney/physiopathology , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/diagnosis , Kidney Failure, Chronic/physiopathology , Male , Mass Spectrometry , Metabolomics/methods , Middle Aged , Time Factors , Uremia/blood , Uremia/diagnosis , Uremia/physiopathology
2.
Dev Cell ; 16(3): 398-410, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19289085

ABSTRACT

Outside cells of the preimplantation mouse embryo form the trophectoderm (TE), a process requiring the transcription factor Tead4. Here, we show that transcriptionally active Tead4 can induce Cdx2 and other trophoblast genes in parallel in embryonic stem cells. In embryos, the Tead4 coactivator protein Yap localizes to nuclei of outside cells, and modulation of Tead4 or Yap activity leads to changes in Cdx2 expression. In inside cells, Yap is phosphorylated and cytoplasmic, and this involves the Hippo signaling pathway component Lats. We propose that active Tead4 promotes TE development in outside cells, whereas Tead4 activity is suppressed in inside cells by cell contact- and Lats-mediated inhibition of nuclear Yap localization. Thus, differential signaling between inside and outside cell populations leads to changes in cell fate specification during TE formation.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Blastocyst Inner Cell Mass/metabolism , DNA-Binding Proteins/metabolism , Muscle Proteins/metabolism , Phosphoproteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Transcription Factors/metabolism , Trophoblasts/metabolism , Adaptor Proteins, Signal Transducing/genetics , Animals , CDX2 Transcription Factor , Cell Cycle Proteins , Cells, Cultured , DNA-Binding Proteins/genetics , Ectoderm/metabolism , Embryo Culture Techniques , Embryonic Stem Cells/metabolism , Female , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Mutant Strains , Mice, Transgenic , Models, Biological , Muscle Proteins/genetics , Phosphoproteins/genetics , Pregnancy , Protein Serine-Threonine Kinases/genetics , Signal Transduction , TEA Domain Transcription Factors , Transcription Factors/genetics , YAP-Signaling Proteins
3.
Genes Dev ; 20(16): 2202-7, 2006 Aug 15.
Article in English | MEDLINE | ID: mdl-16882971

ABSTRACT

MicroRNAs (miRNAs) are short, noncoding RNAs that post-transcriptionally regulate gene expression. While hundreds of mammalian miRNA genes have been identified, little is known about the pathways that regulate the production of active miRNA species. Here we show that a large fraction of miRNA genes are regulated post-transcriptionally. During early mouse development, many miRNA primary transcripts, including the Let-7 family, are present at high levels but are not processed by the enzyme Drosha. An analysis of gene expression in primary tumors indicates that the widespread down-regulation of miRNAs observed in cancer is due to a failure at the Drosha processing step. These data uncover a novel regulatory step in miRNA function and provide a mechanism for miRNA down-regulation in cancer.


Subject(s)
Embryo, Mammalian/metabolism , MicroRNAs/metabolism , Neoplasms/genetics , RNA Processing, Post-Transcriptional , Animals , Blotting, Northern , Cell Line , Cell Line, Tumor , Down-Regulation , Embryonic Development , Female , Mice , MicroRNAs/genetics , Neoplasms/metabolism , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction , Ribonuclease III/metabolism , Stem Cells/metabolism , Teratocarcinoma/genetics , Teratocarcinoma/metabolism , Up-Regulation
4.
Mol Cell Biol ; 26(1): 77-87, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16354681

ABSTRACT

YAP is a multifunctional adapter protein and transcriptional coactivator with several binding partners well described in vitro and in cell culture. To explore in vivo requirements for YAP, we generated mice carrying a targeted disruption of the Yap gene. Homozygosity for the Yap(tm1Smil) allele (Yap-/-) caused developmental arrest around E8.5. Phenotypic characterization revealed a requirement for YAP in yolk sac vasculogenesis. Yolk sac endothelial and erythrocyte precursors were specified as shown by histology, PECAM1 immunostaining, and alpha globin expression. Nonetheless, development of an organized yolk sac vascular plexus failed in Yap-/- embryos. In striking contrast, vasculogenesis proceeded in both the allantois and the embryo proper. Mutant embryos showed patterned gene expression domains along the anteroposterior neuraxis, midline, and streak/tailbud. Despite this evidence of proper patterning and tissue specification, Yap-/- embryos showed developmental perturbations that included a notably shortened body axis, convoluted anterior neuroepithelium, caudal dysgenesis, and failure of chorioallantoic fusion. These results reveal a vital requirement for YAP in the developmental processes of yolk sac vasculogenesis, chorioallantoic attachment, and embryonic axis elongation.


Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Chorioallantoic Membrane/abnormalities , Chorioallantoic Membrane/blood supply , Neovascularization, Physiologic/genetics , Phosphoproteins/genetics , Yolk Sac/abnormalities , Yolk Sac/blood supply , Acyltransferases , Adaptor Proteins, Signal Transducing/metabolism , Animals , Cell Cycle Proteins , Embryo, Mammalian/abnormalities , Embryo, Mammalian/blood supply , Embryo, Mammalian/cytology , Embryonic Development/genetics , Gene Expression , Gene Targeting , Genes, Lethal , Homozygote , Mice , Mice, Mutant Strains , Mutation , Phosphoproteins/metabolism , Proteins/genetics , Proteins/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , YAP-Signaling Proteins , Yolk Sac/cytology
5.
Mol Cell Biol ; 23(13): 4559-72, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12808097

ABSTRACT

Most eukaryotic cells contain nearly equimolar amounts of nucleosomes and H1 linker histones. Despite their abundance and the potential functional specialization of H1 subtypes in multicellular organisms, gene inactivation studies have failed to reveal essential functions for linker histones in vivo. Moreover, in vitro studies suggest that H1 subtypes may not be absolutely required for assembly of chromosomes or nuclei. By sequentially inactivating the genes for three mouse H1 subtypes (H1c, H1d, and H1e), we showed that linker histones are essential for mammalian development. Embryos lacking the three H1 subtypes die by mid-gestation with a broad range of defects. Triple-H1-null embryos have about 50% of the normal ratio of H1 to nucleosomes. Mice null for five of these six H1 alleles are viable but are underrepresented in litters and are much smaller than their littermates. Marked reductions in H1 content were found in certain tissues of these mice and in another compound H1 mutant. These results demonstrate that the total amount of H1 is crucial for proper embryonic development. Extensive reduction of H1 in certain tissues did not lead to changes in nuclear size, but it did result in global shortening of the spacing between nucleosomes.


Subject(s)
Histones/physiology , Nucleosomes/physiology , Alleles , Animals , Cell Nucleus/metabolism , Chromatin/chemistry , Chromatography, High Pressure Liquid , Chromosomes/metabolism , DNA/metabolism , Gene Expression Regulation, Developmental , Genotype , Heterozygote , Histones/chemistry , Histones/metabolism , Homozygote , Mice , Mice, Knockout , Micrococcal Nuclease/metabolism , Models, Biological , Mutation , Nucleosomes/metabolism , Phenotype , Polymerase Chain Reaction , Thymus Gland/metabolism , Time Factors
6.
Development ; 129(16): 3851-60, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12135923

ABSTRACT

The segmental heritage of all vertebrates is evident in the character of the vertebral column. And yet, the extent to which direct translation of pattern from the somitic mesoderm and de novo cell and tissue interactions pattern the vertebral column remains a fundamental, unresolved issue. The elements of vertebral column pattern under debate include both segmental pattern and anteroposterior regional specificity. Understanding how vertebral segmentation and anteroposterior positional identity are patterned requires understanding vertebral column cellular and developmental biology. In this study, we characterized alignment of somites and vertebrae, distribution of individual sclerotome progeny along the anteroposterior axis and development of the axial skeleton in zebrafish. Our clonal analysis of zebrafish sclerotome shows that anterior and posterior somite domains are not lineage-restricted compartments with respect to distribution along the anteroposterior axis but support a 'leaky' resegmentation in development from somite to vertebral column. Alignment of somites with vertebrae suggests that the first two somites do not contribute to the vertebral column. Characterization of vertebral column development allowed examination of the relationship between vertebral formula and expression patterns of zebrafish Hox genes. Our results support co-localization of the anterior expression boundaries of zebrafish hoxc6 homologs with a cervical/thoracic transition and also suggest Hox-independent patterning of regionally specific posterior vertebrae.


Subject(s)
Somites/cytology , Spine/embryology , Zebrafish Proteins , Zebrafish/embryology , Animals , Body Patterning , Gene Expression Regulation, Developmental , Genes, Homeobox , Homeodomain Proteins/genetics , Models, Biological , Spine/cytology , Tail/embryology , Zebrafish/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...